Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018)

Pharma-Bio Serv (PBSV) has disclosed Cash from Discontinued Operations for 1 consecutive years, with 2325159.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Cash from Discontinued Operations changed N/A year-over-year to 2325159.0, compared with a TTM value of 2325159.0 through Jul 2019, changed N/A, and an annual FY2018 reading of 2728726.0, up 447.3% over the prior year.
  • Cash from Discontinued Operations was 2325159.0 for Q4 2018 at Pharma-Bio Serv, up from 559219.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 2325159.0 in Q4 2018 and bottomed at 277995.0 in Q2 2018.